Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet

Shares of Immunocore Holdings PLC Sponsored ADR (IMCR) have gained 6.4% over the past four weeks to close the last trading session at $30.47, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$63.21 indicates a potential upside of 107.5%.The average comprises 14 short-term price targets ranging from a low of $24 to a high of$100, with a standard deviation of $23.20. While the low ...